Evidence map›Paper›PMID 36331539›Full record

ArticleJMIR mental health2022

Development of the First Episode Digital Monitoring mHealth Intervention for People With Early Psychosis: Qualitative Interview Study With Clinicians.

Ana Stefancic, R Tyler Rogers, Sarah Styke, Xiaoyan Xu, Richard Buchsbaum, Ilana Nossel, Leopoldo J Cabassa, T Scott Stroup, David Kimhy

Registry-linked trialAbstract read
In one paragraph

Article in JMIR mental health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04248517 (Using mHealth to Optimize Pharmacotherapy Regimens), which is not on this map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04248517 nacompletednot on this map

Using mHealth to Optimize Pharmacotherapy Regimens

TypeinterventionalSponsorNew York State Psychiatric InstituteRan2020 to 2022Enrolled23ConditionsSchizophrenia, First-Episode PsychosisArmsmHealth Intervention
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ana StefancicDepartment of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.ORCID https://orcid.org/0000-0002-1573-1565
R Tyler RogersDivision of Behavioral Health Services and Policy Research, New York State Psychiatric Institute, New York, NY, United States.ORCID https://orcid.org/0000-0001-5976-2921
Sarah StykeDivision of Behavioral Health Services and Policy Research, New York State Psychiatric Institute, New York, NY, United States.ORCID https://orcid.org/0000-0002-3737-7640
Xiaoyan XuDivision of Behavioral Health Services and Policy Research, New York State Psychiatric Institute, New York, NY, United States.ORCID https://orcid.org/0000-0002-6963-4189
Richard BuchsbaumDepartment of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY, United States.ORCID https://orcid.org/0000-0001-7844-2114
Ilana NosselDepartment of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.ORCID https://orcid.org/0000-0002-6797-0103
Leopoldo J CabassaBrown School of Social Work, Washington University in St Louis, St Louis, MO, United States.ORCID https://orcid.org/0000-0002-1872-4141
T Scott StroupDepartment of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, United States.ORCID https://orcid.org/0000-0002-3123-0672
David KimhyDepartment of Psychiatry, Icahn School of Medicine, New York, NY, United States.ORCID https://orcid.org/0000-0001-7735-9378

Funding

Using mHealth to optimize pharmacotherapy regimensP50MH115843 · NIMH · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI THOMAS SCOTT STROUP · 2018 to 2026
$12.7M
NIMH NIH HHS P50 MH115843
6 · The paper itself

Abstract

backgroundMobile health (mHealth) technologies have been used extensively in psychosis research. In contrast, their integration into real-world clinical care has been limited despite the broad availability of smartphone-based apps targeting mental health care. Most apps developed for treatment of individuals with psychosis have focused primarily on encouraging self-management skills of patients via practicing cognitive behavioral techniques learned during face-to-face clinical sessions (eg, challenging dysfunctional thoughts and relaxation exercises), reminders to engage in health-promoting activities (eg, exercising, sleeping, and socializing), or symptom monitoring. In contrast, few apps have sought to enhance the clinical encounter itself to improve shared decision-making (SDM) and therapeutic relationships with clinicians, which have been linked to positive clinical outcomes.

objectiveThis qualitative study sought clinicians' input to develop First Episode Digital Monitoring (FREEDoM), an app-based mHealth intervention. FREEDoM was designed to improve the quality, quantity, and timeliness of clinical and functional data available to clinicians treating patients experiencing first-episode psychosis (FEP) to enhance their therapeutic relationship and increase SDM.

methodsFollowing the app's initial development, semistructured qualitative interviews were conducted with 11 FEP treatment providers at 3 coordinated specialty care clinics to elicit input on the app's design, the data report for clinicians, and planned usage procedures. We then generated a summary template and conducted matrix analysis to systematically categorize suggested adaptations to the evidence-based intervention using dimensions of the Framework for Reporting Adaptations and Modifications-Enhanced (FRAME) and documented the rationale for adopting or rejecting suggestions.

resultsThe clinicians provided 31 suggestions (18 adopted and 13 rejected). Suggestions to add or refine the content were most common (eg, adding questions in the app). Adaptations to context were most often related to plans for implementing the intervention, how the reported data were displayed to clinicians, and with whom the reports were shared. Reasons for suggestions primarily included factors related to health narratives and priorities of the patients (eg, focus on the functional impact of symptoms vs their severity), providers' clinical judgment (eg, need for clinically relevant information), and organizations' mission and culture. Reasons for rejecting suggestions included requests for data and procedures beyond the intervention's scope, concerns regarding dilution of the intervention's core components, and concerns about increasing patient burden while using the app.

conclusionsFREEDoM focuses on a novel target for the deployment of mHealth technologies in the treatment of FEP patients-the enhancement of SDM and improvement of therapeutic relationships. This study illustrates the use of the FRAME, along with methods and tools for rapid qualitative analysis, to systematically track adaptations to the app as part of its development process. Such adaptations may contribute to enhanced acceptance of the intervention by clinicians and a higher likelihood of integration into clinical care.

trial registrationClinicalTrials.gov NCT04248517; https://tinyurl.com/tjuyxvv6.

Indexed as

coordinated specialty caredigital psychiatryearly psychosisfirst-episode psychosismental health treatmentmobile healthmobile phonequalitativeshared decision-makingsmartphone apps

Identifiers

PMID36331539
PMCPMC9675009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.